1

Country Manager

05.14.2020

Related Articles

Global Pharma Market Access: Pharmacoeconomics in Middle-income Countries

Introduction Many middle-income countries such as Egypt, South Africa, Malaysia, Thailand, and Brazil have pharmacoeconomic guidelines. These follow the recommendations by the International Society for Pharmacoeconomics and Outcomes Research but include country-specific differences. The variations respond to changes in how governments apply pharmacoeconomics and determine market access to pharmaceuticals and medical devices. This is also […]

Read all
What is Value-Based Healthcare: Enablers and Barriers.

What is Value-Based Healthcare? Health is an intrinsic value and a precondition for pursuing a ‘good life’. Whilst universal healthcare provides equitable health to the population, most healthcare systems have strategies to improve quality of healthcare while reducing costs [1] [2]. The promise of value-base healthcare, or care delivered under value-based contracts, is receiving much attention [3]. […]

Read all
The Pharma Market Access Landscape in the Middle East and North Africa: The Next Ten Years

Introduction The market access landscape in the Middle East and North Africa (MENA) is dynamic and rapidly changing. MENA is diverse, comprising many dissimilar countries, with different cultures, including languages, used in commerce. The concerns about the long-term sustainability of oil revenues are driving to shape healthcare markets. There are different approaches to regulating healthcare […]

Read all
Read all articles